Maynard Um
-
-
-
-
-
-
-
HCW Biologics (HCWB) files for 5.69M share offering by selling stockholders
-
-
-
-
-
-
-
HCW Biologics receives $7 million upfront fee for HCW11-006 license
-
-
-
-
-
-
-
HCW Biologics reports positive primate study results for T-cell engager
-
-
-
-
-
-
-
HCW Biologics (HCWB) Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization
-
-
-
-
470,835 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


